Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder

Saloni Shah, Jane P. Kim, Dong Yeon Park, Hyun Kim, Laura D. Yuen, Dennis Do, Bernardo Dell'Osso, Farnaz Hooshmand, Shefali Miller, Po W. Wang, Terence A. Ketter

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.

Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalJournal of Affective Disorders
Volume219
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Anxiety Disorders
Bipolar Disorder
Anxiety
Recurrence
Demography
Therapeutics
Ambulatory Care Facilities
Mood Disorders
Age of Onset
Referral and Consultation
Depression
Research

Keywords

  • Bipolar disorder
  • Current anxiety symptoms
  • Depression
  • Lifetime anxiety disorder
  • Longitudinal

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. / Shah, Saloni; Kim, Jane P.; Park, Dong Yeon; Kim, Hyun; Yuen, Laura D.; Do, Dennis; Dell'Osso, Bernardo; Hooshmand, Farnaz; Miller, Shefali; Wang, Po W.; Ketter, Terence A.

In: Journal of Affective Disorders, Vol. 219, 01.09.2017, p. 165-171.

Research output: Contribution to journalArticle

Shah, Saloni ; Kim, Jane P. ; Park, Dong Yeon ; Kim, Hyun ; Yuen, Laura D. ; Do, Dennis ; Dell'Osso, Bernardo ; Hooshmand, Farnaz ; Miller, Shefali ; Wang, Po W. ; Ketter, Terence A. / Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. In: Journal of Affective Disorders. 2017 ; Vol. 219. pp. 165-171.
@article{e01f6fe08e6148f0bfd03f05abb9d2bb,
title = "Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder",
abstract = "Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0{\%}) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0{\%}) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.",
keywords = "Bipolar disorder, Current anxiety symptoms, Depression, Lifetime anxiety disorder, Longitudinal",
author = "Saloni Shah and Kim, {Jane P.} and Park, {Dong Yeon} and Hyun Kim and Yuen, {Laura D.} and Dennis Do and Bernardo Dell'Osso and Farnaz Hooshmand and Shefali Miller and Wang, {Po W.} and Ketter, {Terence A.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.jad.2017.05.007",
language = "English",
volume = "219",
pages = "165--171",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder

AU - Shah, Saloni

AU - Kim, Jane P.

AU - Park, Dong Yeon

AU - Kim, Hyun

AU - Yuen, Laura D.

AU - Do, Dennis

AU - Dell'Osso, Bernardo

AU - Hooshmand, Farnaz

AU - Miller, Shefali

AU - Wang, Po W.

AU - Ketter, Terence A.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.

AB - Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.

KW - Bipolar disorder

KW - Current anxiety symptoms

KW - Depression

KW - Lifetime anxiety disorder

KW - Longitudinal

UR - http://www.scopus.com/inward/record.url?scp=85019723926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019723926&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2017.05.007

DO - 10.1016/j.jad.2017.05.007

M3 - Article

VL - 219

SP - 165

EP - 171

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -